• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 25, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Measles Vaccine Usage Trends in Children Aged 12-47 Months, 2015-2025

Bioengineer by Bioengineer
July 10, 2026
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study conducted in King County, Washington, provides insightful data on the administration patterns of the measles, mumps, rubella, and varicella (MMRV) vaccine among children. Approximately 15% of children in the region received the combined MMRV vaccine as their initial dose for both measles-containing and varicella-containing vaccines. This proportion has maintained stability over time, highlighting consistent vaccination trends within this population.

The investigation reveals that children who received the MMRV vaccine were disproportionately represented among minoritized racial and ethnic groups. This demographic characteristic is crucial for understanding health equity challenges, as it highlights populations potentially facing unique barriers or preferences in vaccine access and delivery.

Furthermore, the study identifies that these children were more likely to receive a catch-up dose, indicating instances where vaccination schedules may have been delayed or interrupted. Catch-up vaccination is essential for ensuring immunity in children who miss early doses, underscoring the importance of flexible immunization strategies in public health.

An additional factor distinguishing the MMRV recipients was their eligibility for the Vaccines for Children (VFC) program, a federal initiative aimed at providing free vaccines to children who might otherwise not afford them. This association suggests that socioeconomic factors play a significant role in the administration of the MMRV vaccine, emphasizing the need for continued support and funding of such safety-net programs.

Moreover, the data indicate that vaccination at safety-net clinics, often serving under-resourced and vulnerable populations, is more common among those receiving the MMRV vaccine. This pattern further underscores the reliance of specific demographic groups on public health infrastructures for preventive care.

These findings raise important considerations about potential risks if vaccine options become restricted. Limitations in available vaccine formulations could impact minority and vulnerable populations disproportionately, potentially hindering their access to timely and effective immunization.

The implications of this research extend beyond local policy, informing broader discussions on vaccine equity, access, and public health preparedness. As vaccination strategies evolve, maintaining multiple vaccine options may be essential to accommodate diverse population needs and preferences.

This study contributes valuable epidemiological data to the field of infectious diseases and vaccine research, particularly in understanding how social determinants intersect with immunization practices among infants and children.

For more detailed information, the study’s corresponding author, Dr. Eric J. Chow, can be contacted via email at [email protected].

Subject of Research: Vaccine administration patterns among children for measles, mumps, rubella, and varicella (MMRV)
Article Title: Not provided
Keywords: Measles, Mumps, Vaccination, Vaccine Research, Viral Infections, Children, Ethnicity, Racial differences, Risk factors

Tags: catch-up vaccination practicescombined MMRV vaccine usagehealth equity in childhood immunizationsimmunization schedule adherenceimpact of Vaccines for Children (VFC) programMeasles vaccine usage trends in children aged 12-47 monthsMMRV vaccine administration patternspublic health strategies for measles preventionracial and ethnic disparities in vaccine uptakesocioeconomic factors influencing vaccinationvaccination coverage disparitiesvaccination trends in King County Washington

Share12Tweet7Share2ShareShareShare1

Related Posts

How Exercise-Based Cardiac Rehabilitation Reduces Hospitalisation Risk in Coronary Heart Disease

August 25, 2026

Meta-analysis Assesses 2023 International Criteria for Diagnosing MOG Antibody Disease

August 25, 2026

New USC technology delivers clearer MRI scans for the tiniest patients

August 25, 2026

ULK3 Supports Autophagy and Survival of Multiple Myeloma Cells

August 25, 2026

POPULAR NEWS

  • How Exercise-Based Cardiac Rehabilitation Reduces Hospitalisation Risk in Coronary Heart Disease

    29 shares
    Share 12 Tweet 7
  • Meta-analysis Assesses 2023 International Criteria for Diagnosing MOG Antibody Disease

    29 shares
    Share 12 Tweet 7
  • Real-World GUARDIANS Study Evaluates Enfortumab Vedotin–Pembrolizumab in Urothelial Cancer

    29 shares
    Share 12 Tweet 7
  • Comment Evaluates Movement-Focused Intervention for Mobility in Breast Cancer Survivors

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

How Exercise-Based Cardiac Rehabilitation Reduces Hospitalisation Risk in Coronary Heart Disease

Meta-analysis Assesses 2023 International Criteria for Diagnosing MOG Antibody Disease

Real-World GUARDIANS Study Evaluates Enfortumab Vedotin–Pembrolizumab in Urothelial Cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.